Posaconazole Pharmacokinetics in Patients Receiving Chemotherapy or Stem Cell Transplants
Status:
Recruiting
Trial end date:
2021-12-31
Target enrollment:
Participant gender:
Summary
The purpose of the study is to investigate the pharmacokinetics of oral dosage of
Posaconazole which is routinely administered as a standard care prophylaxis for patients
undergoing cancer treatments.